293 related articles for article (PubMed ID: 23436166)
1. Emerging and mechanism-based therapies for recurrent or metastatic Merkel cell carcinoma.
Miller NJ; Bhatia S; Parvathaneni U; Iyer JG; Nghiem P
Curr Treat Options Oncol; 2013 Jun; 14(2):249-63. PubMed ID: 23436166
[TBL] [Abstract][Full Text] [Related]
2. Advances in Immunotherapy for Metastatic Merkel Cell Carcinoma: A Clinician's Guide.
Paulson KG; Bhatia S
J Natl Compr Canc Netw; 2018 Jun; 16(6):782-790. PubMed ID: 29891528
[TBL] [Abstract][Full Text] [Related]
3. Merkel Cell Carcinoma in the Age of Immunotherapy: Facts and Hopes.
Colunga A; Pulliam T; Nghiem P
Clin Cancer Res; 2018 May; 24(9):2035-2043. PubMed ID: 29217527
[TBL] [Abstract][Full Text] [Related]
4. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
Vandeven N; Nghiem P
Immunotherapy; 2016 Jul; 8(8):907-21. PubMed ID: 27381685
[TBL] [Abstract][Full Text] [Related]
5. Scientific and clinical developments in Merkel cell carcinoma: A polyomavirus-driven, often-lethal skin cancer.
Akaike T; Nghiem P
J Dermatol Sci; 2022 Jan; 105(1):2-10. PubMed ID: 34836718
[TBL] [Abstract][Full Text] [Related]
6. Merkel cell carcinoma: recent insights and new treatment options.
Schrama D; Ugurel S; Becker JC
Curr Opin Oncol; 2012 Mar; 24(2):141-9. PubMed ID: 22234254
[TBL] [Abstract][Full Text] [Related]
7. Merkel cell carcinoma: Do you know your guidelines?
Miles BA; Goldenberg D;
Head Neck; 2016 May; 38(5):647-52. PubMed ID: 26716756
[TBL] [Abstract][Full Text] [Related]
8. Update on the biology and clinical management of Merkel cell carcinoma.
Thakuria M; LeBoeuf NR; Rabinowits G
Am Soc Clin Oncol Educ Book; 2014; ():e405-10. PubMed ID: 24857131
[TBL] [Abstract][Full Text] [Related]
9. [Merkel cell carcinoma: a highly aggressive tumor with possible viral etiology].
Toberer F; Werchau S; Bischof M; Büchler M; Enk A; Helmbold P
Chirurg; 2011 Aug; 82(8):653-60. PubMed ID: 21290092
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in the understanding of the genetics, etiology, and treatment of Merkel cell carcinoma.
Donepudi S; DeConti RC; Samlowski WE
Semin Oncol; 2012 Apr; 39(2):163-72. PubMed ID: 22484188
[TBL] [Abstract][Full Text] [Related]
11. Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs.
Schadendorf D; Lebbé C; Zur Hausen A; Avril MF; Hariharan S; Bharmal M; Becker JC
Eur J Cancer; 2017 Jan; 71():53-69. PubMed ID: 27984768
[TBL] [Abstract][Full Text] [Related]
12. Merkel cell polyomavirus in merkel cell carcinoma: clinical and therapeutic perspectives.
Samimi M; Gardair C; Nicol JT; Arnold F; Touzé A; Coursaget P
Semin Oncol; 2015 Apr; 42(2):347-58. PubMed ID: 25843739
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary Treatment, Including Locoregional Chemotherapy, for Merkel-Polyomavirus-Positive Merkel Cell Carcinomas: Perspectives for Patients Exhibiting Oncogenic Alternative Δ exon 6-7 TrkAIII Splicing of Neurotrophin Receptor Tropomyosin-Related Kinase A.
Guadagni S; Farina AR; Cappabianca LA; Sebastiano M; Maccarone R; Zelli V; Clementi M; Chiominto A; Bruera G; Ricevuto E; Fiorentini G; Sarti D; Mackay AR
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153070
[TBL] [Abstract][Full Text] [Related]
14. Quality Is King: Fundamental Insights into Tumor Antigenicity from Virus-Associated Merkel Cell Carcinoma.
Lahman MC; Paulson KG; Nghiem PT; Chapuis AG
J Invest Dermatol; 2021 Aug; 141(8):1897-1905. PubMed ID: 33863500
[TBL] [Abstract][Full Text] [Related]
15. Immunobiology of Merkel cell carcinoma: implications for immunotherapy of a polyomavirus-associated cancer.
Bhatia S; Afanasiev O; Nghiem P
Curr Oncol Rep; 2011 Dec; 13(6):488-97. PubMed ID: 21953511
[TBL] [Abstract][Full Text] [Related]
16. Merkel cell carcinoma: emerging biology, current approaches, and future directions.
Tothill R; Estall V; Rischin D
Am Soc Clin Oncol Educ Book; 2015; ():e519-26. PubMed ID: 25993218
[TBL] [Abstract][Full Text] [Related]
17. Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell Carcinoma.
Garcia-Carbonero R; Marquez-Rodas I; de la Cruz-Merino L; Martinez-Trufero J; Cabrera MA; Piulats JM; Capdevila J; Grande E; Martin-Algarra S; Berrocal A
Oncologist; 2019 Oct; 24(10):1375-1383. PubMed ID: 30962295
[TBL] [Abstract][Full Text] [Related]
18. Updates on Merkel Cell Carcinoma.
Emge DA; Cardones AR
Dermatol Clin; 2019 Oct; 37(4):489-503. PubMed ID: 31466589
[TBL] [Abstract][Full Text] [Related]
19. Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.
Laude HC; Jonchère B; Maubec E; Carlotti A; Marinho E; Couturaud B; Peter M; Sastre-Garau X; Avril MF; Dupin N; Rozenberg F
PLoS Pathog; 2010 Aug; 6(8):e1001076. PubMed ID: 20865165
[TBL] [Abstract][Full Text] [Related]
20. Expression of the IDO1/TDO2-AhR pathway in tumor cells or the tumor microenvironment is associated with Merkel cell polyomavirus status and prognosis in Merkel cell carcinoma.
Wardhani LO; Matsushita M; Iwasaki T; Kuwamoto S; Nonaka D; Nagata K; Kato M; Kitamura Y; Hayashi K
Hum Pathol; 2019 Feb; 84():52-61. PubMed ID: 30240768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
